Cargando…
P1016: POLYCYTHEMIA VERA AND IMMUNE THROMBOGENESIS
Autores principales: | Cacciola, R., Vecchio, V., Gentilini Cacciola, E., CACCIOLA, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431295/ http://dx.doi.org/10.1097/01.HS9.0000846932.15401.d7 |
Ejemplares similares
-
Impact of Anti-Endothelial Cell Antibodies (AECAs) in Patients with Polycythemia Vera and Thrombosis
por: Cacciola, Rossella, et al.
Publicado: (2022) -
P1016: RUSFERTIDE (PTG-300) IMPROVES POLYCYTHEMIA VERA (PV) RELATED SYMPTOMS IN PV PATIENTS
por: Kuykendall, Andrew, et al.
Publicado: (2023) -
Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy
por: Cacciola, Rossella, et al.
Publicado: (2021) -
Vaccine-Induced Thrombotic Thrombocytopenia: Novelty Testing in the Diagnostic Work-up?
por: Cacciola, Rossella Rosari, et al.
Publicado: (2021) -
P1036: VOLUMETRIC SPLENOMEGALY IN PATIENTS WITH POLYCYTHEMIA VERA
por: Lee, M.-W., et al.
Publicado: (2022)